4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000100
General Counsel sold 10,000 shares at an average $93.64 ($936,417)
- General Counsel acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quinlan Paul T General Counsel | 2026-09-21 | Option exercise 10b5-1 | +10,000 | $7.80 | $78,000 | 39,995 | D: show line 1 in the form |
| Quinlan Paul T General Counsel | 2026-09-21 | Sale 10b5-1 | −2,900 | $92.37 | $267,870 | 37,095 | D: show line 2 in the form |
| Quinlan Paul T General Counsel | 2026-09-21 | Sale 10b5-1 | −3,832 | $93.32 | $357,592 | 33,263 | D: show line 3 in the form |
| Quinlan Paul T General Counsel | 2026-09-21 | Sale 10b5-1 | −601 | $94.44 | $56,760 | 32,662 | D: show line 4 in the form |
| Quinlan Paul T General Counsel | 2026-09-21 | Sale 10b5-1 | −2,667 | $95.31 | $254,196 | 29,995 | D: show line 5 in the form |
| Open-market sales · 10,000 sh · avg $93.64 · $936,417 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quinlan Paul T General Counsel | 2026-09-21 | Option exercise · Employee Warrant (right to buy) 10b5-1 | −10,000 | 79,996 | D: show line 6 in the form |
Loading xslF345X06/form4.xml…